Interestingly, however, in both cases c-Met acts as a direct Src substrate in an in vitro immunocomplex kinase assay system, which suggests that Src-dependent cell survival is also regulated by c-Met receptor activation, at least in head and neck cancer cells [95]. This evidence concerns the gene MET and head and neck cancer.